Cargando…
Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
Resistant hypertension (RH) is characterized by the use of three or more antihypertensive drugs without reaching the goal of controlling blood pressure (BP). For a definitive diagnosis of RH, it is necessary to exclude causes of pseudoresistance, including the white-coat effect, errors in BP measure...
Autores principales: | Zanatta, João Marcos de Menezes, Cosenso-Martin, Luciana Neves, da Silva Lopes, Valquíria, Roma Uyemura, Jéssica Rodrigues, Polegati Santos, Aleandra Marton, Paz Landim, Manoel Ildefonso, Yugar-Toledo, Juan Carlos, Vilela-Martin, José Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887157/ https://www.ncbi.nlm.nih.gov/pubmed/33603455 http://dx.doi.org/10.2147/IBPC.S264057 |
Ejemplares similares
-
Predictive Factors for Target Organ Injuries in Hypertensive Individuals
por: Paz Landim, Manoel, et al.
Publicado: (2021) -
The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
por: Giollo-Junior, Luiz Tadeu, et al.
Publicado: (2023) -
Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
por: Cestário, Elizabeth do Espirito Santo, et al.
Publicado: (2018) -
Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)
por: Cestario, Elizabeth do Espirito Santo, et al.
Publicado: (2022) -
“Resistance Is Futile”: A Pilot Study into Pseudoresistance in Canine Epilepsy
por: Kajin, Filip, et al.
Publicado: (2023)